Shareholders of GlaxoSmithKline Consumer Nigeria Plc have called on the board and management and federal government to save the company from the brink of collapse, even as they approved an N657.73 million dividend declared at the company’s 52nd Annual General Meeting.
Moses Igbrude, national co
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Josephine Okojie-Okeiyi
Josephine Okojie-Okeiyi is a journalist with over five years’ reporting experience. She writes on industry, agriculture, commodities, climate change, and environmental issues.
She is fellow of Thomson Reuters Foundation and Bloomberg Media Initiative for Africa.
